GCSH

Glycine cleavage system protein H (aminomethyl carrier)
Identifiers
Symbols GCSH ; GCE; NKH
External IDs OMIM: 238330 MGI: 1915383 HomoloGene: 90880 GeneCards: GCSH Gene
Orthologs
Species Human Mouse
Entrez 2653 68133
Ensembl ENSG00000140905 ENSMUSG00000034424
UniProt P23434 Q91WK5
RefSeq (mRNA) NM_004483 NM_026572
RefSeq (protein) NP_004474 NP_080848
Location (UCSC) Chr 16:
81.08 – 81.1 Mb		 Chr 8:
116.98 – 116.99 Mb
PubMed search

Glycine cleavage system H protein, mitochondrial (abbreviated as GCSH) is a protein that in humans is encoded by the GCSH gene.[1][2][3] Degradation of glycine is brought about by the glycine cleavage system (GCS), which is composed of 4 protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein; this protein), T protein (a tetrahydrofolate-requiring aminomethyltransferase enzyme), and L protein (a lipoamide dehydrogenase).[3] The H protein shuttles the methylamine group of glycine from the P protein to the T protein. The protein encoded by GCSH gene is the H protein, which transfers the methylamine group of glycine from the P protein to the T protein.[4] Defects in this gene are a cause of nonketotic hyperglycinemia (NKH).[5] Two transcript variants, one protein-coding and the other probably not protein-coding,have been found for this gene. Also, several transcribed and non-transcribed pseudogenes of this gene exist throughout the genome.[6]

Function

The glycine cleavage system (GCS) is the major physiological pathway for glycine degradation in mammals and is confined to mitochondria of the liver, kidney, small intestine, pituitary, thyroid glands, and brain.[7]The P-protein is a pyridoxal phosphate-dependent glycine decarboxylase that transfers the methylamine moiety of glycine to one of the thiol groups in the lipoyl component of H-protein, a hydrogen-carrier protein and the second component of the complex. The T-protein catalyzes the release of ammonia and transfer of the one-carbon fragment from the intermediate lipoyl residue to tetrahydrofolate, while the L-protein, a lipoamide dehydrogenase, catalyzes the oxidation of the dihydrolipoyl residue of H-protein and reduction of NAD.[8]

Structure

Gene

Human GCSH gene has 5 exons spanning 13.5kb and resides on chromosome 16 at q23.2.[4]

Protein

The GCSH is a heat-stable small protein with a covalently attached lipoic acid prosthetic group which interacts with the three enzymes during the catalysis. The chemically determined amino acid sequence revealed that chicken H-protein is composed of 125 amino acids with a lipoic acid prosthetic group at lysine 59 (Lys59).[2] Because of its restricted tissue expression in humans, H-protein purified from chicken liver has been routinely used for the assay.[9] The H-protein comprises a mitochondrial targeting sequence and a mature mitochondrial matrix protein sequence. Its activation in vivo requires the attachment of a lipoic acid prosthetic group at Lys59 of the mature protein.[4] The matrix protein sequence is highly conserved and chicken H-protein has 85.6% amino acid sequence similarity to the human form.[10]

Clinical significance

Nonketotic hyperglycinemia (NKH) is an inborn error of metabolism caused by deficiency in the glycine cleavage system (GCS).[11] Enzymatic analysis has identified three metabolic lesions in NKH, deficiencies of P-, T-, and H-proteins.[6] The first mutation identified in NKH was in the P-protein gene.[12] Subsequently, some patients were found to have mutations in the T-protein gene.[13] The structure, polymorphism, and expression of GCSH could facilitate the molecular analysis of patients with variant forms of NKH that are caused by H-protein deficiency.[4]

Interactions

GCSH has been shown to interact with the other glycine cleavage system protein components: P protein, T protein and L protein.[6][4]

References

  1. ↑ Koyata H, Hiraga K (Feb 1991). "The glycine cleavage system: structure of a cDNA encoding human H-protein, and partial characterization of its gene in patients with hyperglycinemias". American Journal of Human Genetics 48 (2): 351–61. PMC 1683031. PMID 1671321.
  2. 1 2 Fujiwara K, Okamura-Ikeda K, Hayasaka K, Motokawa Y (Apr 1991). "The primary structure of human H-protein of the glycine cleavage system deduced by cDNA cloning". Biochemical and Biophysical Research Communications 176 (2): 711–6. doi:10.1016/S0006-291X(05)80242-6. PMID 2025283.
  3. 1 2 "Entrez Gene: GCSH glycine cleavage system protein H (aminomethyl carrier)".
  4. 1 2 3 4 5 Kure S, Kojima K, Kudo T, Kanno K, Aoki Y, Suzuki Y, Shinka T, Sakata Y, Narisawa K, Matsubara Y (2001). "Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human H-protein gene of the glycine cleavage system (GCSH), a candidate gene for nonketotic hyperglycinemia". Journal of Human Genetics 46 (7): 378–84. doi:10.1007/s100380170057. PMID 11450847.
  5. ↑ Kikuchi G (Jun 1973). "The glycine cleavage system: composition, reaction mechanism, and physiological significance". Molecular and Cellular Biochemistry 1 (2): 169–87. doi:10.1007/bf01659328. PMID 4585091.
  6. 1 2 3 Zay A, Choy FY, Patrick C, Sinclair G (Jun 2011). "Glycine cleavage enzyme complex: molecular cloning and expression of the H-protein cDNA from cultured human skin fibroblasts". Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire 89 (3): 299–307. doi:10.1139/o10-156. PMID 21539457.
  7. ↑ Kikuchi G, Motokawa Y, Yoshida T, Hiraga K (2008). "Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences 84 (7): 246–63. doi:10.2183/pjab.84.246. PMID 18941301.
  8. ↑ Hiraga K, Kure S, Yamamoto M, Ishiguro Y, Suzuki T (Mar 1988). "Cloning of cDNA encoding human H-protein, a constituent of the glycine cleavage system". Biochemical and Biophysical Research Communications 151 (2): 758–62. doi:10.1016/s0006-291x(88)80345-0. PMID 3348809.
  9. ↑ Fujiwara K, Okamura-Ikeda K, Motokawa Y (Jul 1986). "Chicken liver H-protein, a component of the glycine cleavage system. Amino acid sequence and identification of the N epsilon-lipoyllysine residue". The Journal of Biological Chemistry 261 (19): 8836–41. PMID 3522581.
  10. ↑ Choy F, Sharp L, Applegarth DA (2000). "Glycine cleavage enzyme complex: rabbit H-protein cDNA sequence analysis and comparison to human, cow, and chicken". Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire 78 (6): 725–30. doi:10.1139/bcb-78-6-725. PMID 11206584.
  11. ↑ Tada K, Narisawa K, Yoshida T, Konno T, Yokoyama Y (Jul 1969). "Hyperglycinemia: a defect in glycine cleavage reaction". The Tohoku Journal of Experimental Medicine 98 (3): 289–96. doi:10.1620/tjem.98.289. PMID 5307488.
  12. ↑ Kure S, Narisawa K, Tada K (Feb 1991). "Structural and expression analyses of normal and mutant mRNA encoding glycine decarboxylase: three-base deletion in mRNA causes nonketotic hyperglycinemia". Biochemical and Biophysical Research Communications 174 (3): 1176–82. doi:10.1016/0006-291x(91)91545-n. PMID 1996985.
  13. ↑ Kure S, Mandel H, Rolland MO, Sakata Y, Shinka T, Drugan A, Boneh A, Tada K, Matsubara Y, Narisawa K (Apr 1998). "A missense mutation (His42Arg) in the T-protein gene from a large Israeli-Arab kindred with nonketotic hyperglycinemia". Human Genetics 102 (4): 430–4. doi:10.1007/s004390050716. PMID 9600239.

Further reading

  • Hiraga K, Kure S, Yamamoto M, Ishiguro Y, Suzuki T (Mar 1988). "Cloning of cDNA encoding human H-protein, a constituent of the glycine cleavage system". Biochemical and Biophysical Research Communications 151 (2): 758–62. doi:10.1016/S0006-291X(88)80345-0. PMID 3348809. 
  • Gründig E, Birnbaumer E, Hawrylewicz A (1981). "Influence of phenothiazines or reserpine on the formation of 14C-glycine from U-14C-serine". Enzyme 26 (1): 43–8. PMID 6111451. 
  • Hiraga K, Kochi H, Hayasaka K, Kikuchi G, Nyhan WL (Aug 1981). "Defective glycine cleavage system in nonketotic hyperglycinemia. Occurrence of a less active glycine decarboxylase and an abnormal aminomethyl carrier protein". The Journal of Clinical Investigation 68 (2): 525–34. doi:10.1172/JCI110284. PMC 370827. PMID 6790577. 
  • Kure S, Kojima K, Kudo T, Kanno K, Aoki Y, Suzuki Y, Shinka T, Sakata Y, Narisawa K, Matsubara Y (2001). "Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human H-protein gene of the glycine cleavage system (GCSH), a candidate gene for nonketotic hyperglycinemia". Journal of Human Genetics 46 (7): 378–84. doi:10.1007/s100380170057. PMID 11450847. 
  • Kure S, Kojima K, Ichinohe A, Maeda T, Kalmanchey R, Fekete G, Berg SZ, Filiano J, Aoki Y, Suzuki Y, Izumi T, Matsubara Y (Nov 2002). "Heterozygous GLDC and GCSH gene mutations in transient neonatal hyperglycinemia". Annals of Neurology 52 (5): 643–6. doi:10.1002/ana.10367. PMID 12402263. 
  • Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (Oct 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514. 
This article is issued from Wikipedia - version of the Wednesday, January 27, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.